Approximately 89% of patients with bPHEOs develop multiple endocrine neoplasia type 2 (MEN2) caused by germline mutation of the RET (rearranged during transfection) proto-oncogene and von Hippel–Lindau (VHL) disease caused by the VHL gene (1). The gene discussed is RET; the disease is multiple endocrine neoplasia type 2.